Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cellsConsalvo Petti(Candiolo Cancer Institute), Enzo Médico(Candiolo Cancer Institute)OncotargetNovember 15, 201410.18632/oncotarget.2771Cited by 18SaveCiteExport RISWatch citationsRelated PapersThe molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets|Nature Communications|2015|305Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways|Cancers|2021|12